Ovid Therapeutics Inc. · NASDAQ:OVID
BIOTECHNOLOGY VALUE FUND L P's stake in Ovid Therapeutics Inc. fell below 5% (Schedule 13G/A)
Event Jul 17, 2025 · Filed Jul 21, 2025
BIOTECHNOLOGY VALUE FUND L P's stake in Ovid Therapeutics Inc. fell below 5%, 0 shares, as a passive investor on Jul 17, 2025. Filed Jul 21, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 0% | 0 |
| BVF I GP LLC | 0% | 0 |
| BIOTECHNOLOGY VALUE FUND II LP | 0% | 0 |
| BVF II GP LLC | 0% | 0 |
| Biotechnology Value Trading Fund OS LP | 0% | 0 |
| BVF Partners OS Ltd. | 0% | 0 |
| BVF GP HOLDINGS LLC | 0% | 0 |
| BVF PARTNERS L P/IL | 0% | 0 |
| BVF INC/IL | 0% | 0 |
| LAMPERT MARK N | 0% | 0 |
Source
Related
- Ovid Therapeutics Inc.
- Bvf Partners L P
- Ovid Therapeutics Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026